Contact
searchSearch
HMP Global

Respiratory Syncytial Virus Topic Center

Featured Article

News
Study Finds RSV Positivity Not Linked to Higher Mortality in Adults With Acute Respiratory Illness
03/17/2025
Grace Taylor, MS, MA
Research from a Centers for Disease Control and Prevention (CDC)-supported surveillance network shows that respiratory syncytial virus (RSV) positivity in adults with acute respiratory illness is not associated with an increased risk of death...
Research from a Centers for Disease Control and Prevention (CDC)-supported surveillance network shows that respiratory syncytial virus (RSV) positivity in adults with acute respiratory illness is not associated with an increased risk of death...
Research from a Centers for...
03/17/2025
Pharmacy Learning Network
News
RSV Vaccine Demonstrates High Effectiveness in Preventing Severe Respiratory Disease in Older Adults
01/21/2025
Lisa Kuhns, PhD, MD
The RSV vaccine Abrysvo (RSVpreF) is highly effective in preventing severe respiratory syncytial virus (RSV) infections in adults aged 60 and older.
The RSV vaccine Abrysvo (RSVpreF) is highly effective in preventing severe respiratory syncytial virus (RSV) infections in adults aged 60 and older.
The RSV vaccine Abrysvo...
01/21/2025
Pharmacy Learning Network
News
Adjuvanted Vaccines May Increase RSV-Neutralizing Antibody Levels in Immunocompromised Individuals, Study Finds
01/10/2025
Lisa Kuhns, PhD, MD
Older adults with weakened immune systems, such as organ transplant recipients on immunosuppressive medications, respond less robustly to respiratory syncytial virus (RSV) vaccines than their peers with normal immune function.
Older adults with weakened immune systems, such as organ transplant recipients on immunosuppressive medications, respond less robustly to respiratory syncytial virus (RSV) vaccines than their peers with normal immune function.
Older adults with weakened...
01/10/2025
Pharmacy Learning Network
News
RSVpreF Vaccine Demonstrates Strong Efficacy and Safety Against RSV Infections
12/17/2024
Lisa Kuhns, PhD, MD
Revaccination with the bivalent respiratory syncytial virus (RSV) prefusion F (RSV-preF) vaccination 12 months after initial vaccination was well tolerated and immunogenic in healthy adults.
Revaccination with the bivalent respiratory syncytial virus (RSV) prefusion F (RSV-preF) vaccination 12 months after initial vaccination was well tolerated and immunogenic in healthy adults.
Revaccination with the bivalent...
12/17/2024
Pharmacy Learning Network
News
Respiratory Syncytial Virus Subgroups A and B Contribute Equally to the Global RSV Burden, Study Finds
12/06/2024
Lisa Kuhns, PhD, MD
Respiratory syncytial virus (RSV) A and B contribute to the global RSV burden, and both subgroups cause severe disease, with no available evidence suggesting differences in clinical severity between the subgroups, according to a study...
Respiratory syncytial virus (RSV) A and B contribute to the global RSV burden, and both subgroups cause severe disease, with no available evidence suggesting differences in clinical severity between the subgroups, according to a study...
Respiratory syncytial virus...
12/06/2024
Pharmacy Learning Network
News
Community Pharmacies Play a Pivotal Role in Boosting RSV Vaccine Uptake in Older Adults
11/22/2024
Juliet Gallagher
Despite its prevalence and the availability of a respiratory syncytial virus (RSV) vaccine approved in May 2023, awareness of RSV and its vaccine remains limited, and community pharmacies have the potential play a pivotal role in addressing...
Despite its prevalence and the availability of a respiratory syncytial virus (RSV) vaccine approved in May 2023, awareness of RSV and its vaccine remains limited, and community pharmacies have the potential play a pivotal role in addressing...
Despite its prevalence and the...
11/22/2024
Pharmacy Learning Network
News
Tracking RSV Evolution and Treatment Resistance Through Genomic Surveillance
11/08/2024
Juliet Gallagher
The Minnesota Department of Health recently expanded its viral genomic surveillance program expanded to include human respiratory syncytial virus to track genetic diversity and investigate viral circulation dynamics using whole-genome...
The Minnesota Department of Health recently expanded its viral genomic surveillance program expanded to include human respiratory syncytial virus to track genetic diversity and investigate viral circulation dynamics using whole-genome...
The Minnesota Department of...
11/08/2024
Pharmacy Learning Network
News
Study Sheds Light on RSV Structural Protein Organization, Paving the Way for Vaccine Improvements
10/18/2024
Lisa Kuhns, PhD, MD
A new study published in Nature Communications has provided crucial insights into the structure and organization of respiratory syncytial virus (RSV).
A new study published in Nature Communications has provided crucial insights into the structure and organization of respiratory syncytial virus (RSV).
A new study published in Nature...
10/18/2024
Pharmacy Learning Network
News
RSV Identified as Significant Contributor to COPD Exacerbations
10/04/2024
Lisa Kuhns, PhD, MD
Respiratory syncytial virus (RSV) is linked to approximately 8.7% of chronic obstructive pulmonary disease (COPD) exacerbations in European cohorts, with RSV-related exacerbations showing a tendency to resolve more quickly than those caused...
Respiratory syncytial virus (RSV) is linked to approximately 8.7% of chronic obstructive pulmonary disease (COPD) exacerbations in European cohorts, with RSV-related exacerbations showing a tendency to resolve more quickly than those caused...
Respiratory syncytial virus...
10/04/2024
Pharmacy Learning Network
News
Comprehensive Review Reveals Substantial Burden of Respiratory Syncytial Virus in Adults Worldwide
09/10/2024
Lisa Kuhns, PhD, MD
Respiratory syncytial virus (RSV) poses a significant health risk, particularly for older adults and those with underlying health conditions, according to a study published in The Journal of Infectious Diseases.
Respiratory syncytial virus (RSV) poses a significant health risk, particularly for older adults and those with underlying health conditions, according to a study published in The Journal of Infectious Diseases.
Respiratory syncytial virus...
09/10/2024
Pharmacy Learning Network
News
Approach Allows for Rapid Detection of 8 Respiratory Viruses
08/26/2024
Jolynn Tumolo
A combination of bioinformatics analysis and nanomaterial optimization improves the sensitivity, specificity, and detection rate of viral diagnosis of respiratory viruses, according to a study published in Frontiers and Biotechnology.
A combination of bioinformatics analysis and nanomaterial optimization improves the sensitivity, specificity, and detection rate of viral diagnosis of respiratory viruses, according to a study published in Frontiers and Biotechnology.
A combination of bioinformatics...
08/26/2024
Pharmacy Learning Network

Newsfeed

News
Study Finds RSV Positivity Not Linked to Higher Mortality in Adults With Acute Respiratory Illness
03/17/2025
Grace Taylor, MS, MA
Research from a Centers for Disease Control and Prevention (CDC)-supported surveillance network shows that respiratory syncytial virus (RSV) positivity in adults with acute respiratory illness is not associated with an increased risk of death...
Research from a Centers for Disease Control and Prevention (CDC)-supported surveillance network shows that respiratory syncytial virus (RSV) positivity in adults with acute respiratory illness is not associated with an increased risk of death...
Research from a Centers for...
03/17/2025
Pharmacy Learning Network
News
RSV Vaccine Demonstrates High Effectiveness in Preventing Severe Respiratory Disease in Older Adults
01/21/2025
Lisa Kuhns, PhD, MD
The RSV vaccine Abrysvo (RSVpreF) is highly effective in preventing severe respiratory syncytial virus (RSV) infections in adults aged 60 and older.
The RSV vaccine Abrysvo (RSVpreF) is highly effective in preventing severe respiratory syncytial virus (RSV) infections in adults aged 60 and older.
The RSV vaccine Abrysvo...
01/21/2025
Pharmacy Learning Network
News
Adjuvanted Vaccines May Increase RSV-Neutralizing Antibody Levels in Immunocompromised Individuals, Study Finds
01/10/2025
Lisa Kuhns, PhD, MD
Older adults with weakened immune systems, such as organ transplant recipients on immunosuppressive medications, respond less robustly to respiratory syncytial virus (RSV) vaccines than their peers with normal immune function.
Older adults with weakened immune systems, such as organ transplant recipients on immunosuppressive medications, respond less robustly to respiratory syncytial virus (RSV) vaccines than their peers with normal immune function.
Older adults with weakened...
01/10/2025
Pharmacy Learning Network
News
RSVpreF Vaccine Demonstrates Strong Efficacy and Safety Against RSV Infections
12/17/2024
Lisa Kuhns, PhD, MD
Revaccination with the bivalent respiratory syncytial virus (RSV) prefusion F (RSV-preF) vaccination 12 months after initial vaccination was well tolerated and immunogenic in healthy adults.
Revaccination with the bivalent respiratory syncytial virus (RSV) prefusion F (RSV-preF) vaccination 12 months after initial vaccination was well tolerated and immunogenic in healthy adults.
Revaccination with the bivalent...
12/17/2024
Pharmacy Learning Network
News
Respiratory Syncytial Virus Subgroups A and B Contribute Equally to the Global RSV Burden, Study Finds
12/06/2024
Lisa Kuhns, PhD, MD
Respiratory syncytial virus (RSV) A and B contribute to the global RSV burden, and both subgroups cause severe disease, with no available evidence suggesting differences in clinical severity between the subgroups, according to a study...
Respiratory syncytial virus (RSV) A and B contribute to the global RSV burden, and both subgroups cause severe disease, with no available evidence suggesting differences in clinical severity between the subgroups, according to a study...
Respiratory syncytial virus...
12/06/2024
Pharmacy Learning Network
News
Community Pharmacies Play a Pivotal Role in Boosting RSV Vaccine Uptake in Older Adults
11/22/2024
Juliet Gallagher
Despite its prevalence and the availability of a respiratory syncytial virus (RSV) vaccine approved in May 2023, awareness of RSV and its vaccine remains limited, and community pharmacies have the potential play a pivotal role in addressing...
Despite its prevalence and the availability of a respiratory syncytial virus (RSV) vaccine approved in May 2023, awareness of RSV and its vaccine remains limited, and community pharmacies have the potential play a pivotal role in addressing...
Despite its prevalence and the...
11/22/2024
Pharmacy Learning Network
News
Tracking RSV Evolution and Treatment Resistance Through Genomic Surveillance
11/08/2024
Juliet Gallagher
The Minnesota Department of Health recently expanded its viral genomic surveillance program expanded to include human respiratory syncytial virus to track genetic diversity and investigate viral circulation dynamics using whole-genome...
The Minnesota Department of Health recently expanded its viral genomic surveillance program expanded to include human respiratory syncytial virus to track genetic diversity and investigate viral circulation dynamics using whole-genome...
The Minnesota Department of...
11/08/2024
Pharmacy Learning Network
News
Study Sheds Light on RSV Structural Protein Organization, Paving the Way for Vaccine Improvements
10/18/2024
Lisa Kuhns, PhD, MD
A new study published in Nature Communications has provided crucial insights into the structure and organization of respiratory syncytial virus (RSV).
A new study published in Nature Communications has provided crucial insights into the structure and organization of respiratory syncytial virus (RSV).
A new study published in Nature...
10/18/2024
Pharmacy Learning Network
News
RSV Identified as Significant Contributor to COPD Exacerbations
10/04/2024
Lisa Kuhns, PhD, MD
Respiratory syncytial virus (RSV) is linked to approximately 8.7% of chronic obstructive pulmonary disease (COPD) exacerbations in European cohorts, with RSV-related exacerbations showing a tendency to resolve more quickly than those caused...
Respiratory syncytial virus (RSV) is linked to approximately 8.7% of chronic obstructive pulmonary disease (COPD) exacerbations in European cohorts, with RSV-related exacerbations showing a tendency to resolve more quickly than those caused...
Respiratory syncytial virus...
10/04/2024
Pharmacy Learning Network
News
Comprehensive Review Reveals Substantial Burden of Respiratory Syncytial Virus in Adults Worldwide
09/10/2024
Lisa Kuhns, PhD, MD
Respiratory syncytial virus (RSV) poses a significant health risk, particularly for older adults and those with underlying health conditions, according to a study published in The Journal of Infectious Diseases.
Respiratory syncytial virus (RSV) poses a significant health risk, particularly for older adults and those with underlying health conditions, according to a study published in The Journal of Infectious Diseases.
Respiratory syncytial virus...
09/10/2024
Pharmacy Learning Network
News
Testosterone Cypionate Injection Recalled Due to Crystallization Concerns
04/23/2025
Juliet Gallagher
Eugia US LLC has voluntarily recalled 36,816 vials of Testosterone Cypionate Injection, USP, CIII, 200 mg/mL, distributed in 1 mL single-dose vials (NDC 55150-277-01).
Eugia US LLC has voluntarily recalled 36,816 vials of Testosterone Cypionate Injection, USP, CIII, 200 mg/mL, distributed in 1 mL single-dose vials (NDC 55150-277-01).
Eugia US LLC has voluntarily...
04/23/2025
Pharmacy Learning Network
News
Class II Recall Issued for Unisom Sleep Aid Due to Nitrosamine Impurities
04/23/2025
Juliet Gallagher
Chattem Inc. has voluntarily initiated a Class II recall of its Unisom SleepMinis (Diphenhydramine HCl) 25 mg mini-capsules, distributed in 60-count bottles nationwide.
Chattem Inc. has voluntarily initiated a Class II recall of its Unisom SleepMinis (Diphenhydramine HCl) 25 mg mini-capsules, distributed in 60-count bottles nationwide.
Chattem Inc. has voluntarily...
04/23/2025
Pharmacy Learning Network
News
FDA Issues Class I Recall for Levetiracetam Injection Due to Labeling Discrepancy
04/23/2025
Juliet Gallagher
Dr Reddy’s Laboratories Inc. has initiated a Class I recall of levetiracetam 0.75% in sodium chloride injection following the discovery of a labeling discrepancy that could pose serious health risks.
Dr Reddy’s Laboratories Inc. has initiated a Class I recall of levetiracetam 0.75% in sodium chloride injection following the discovery of a labeling discrepancy that could pose serious health risks.
Dr Reddy’s Laboratories Inc. has...
04/23/2025
Pharmacy Learning Network
News
FDA Issues Class II Recall for Sodium Chloride Irrigation Solution Due to Particulate Contamination
04/17/2025
Hannah Musick
The US Food and Drug Administration (FDA) has issued a Class II recall for Sodium Chloride Irrigation Solution due to the presence of particulate matter, posing a potential risk during surgical and wound care procedures.
The US Food and Drug Administration (FDA) has issued a Class II recall for Sodium Chloride Irrigation Solution due to the presence of particulate matter, posing a potential risk during surgical and wound care procedures.
The US Food and Drug...
04/17/2025
Pharmacy Learning Network
News
Gabapentin Capsules Recalled Due to Cross-Contamination Concerns
04/17/2025
Hannah Musick
Select lots of nationally distributed Gabapentin Capsules are being recalled due to cross contamination concerns.
Select lots of nationally distributed Gabapentin Capsules are being recalled due to cross contamination concerns.
Select lots of nationally...
04/17/2025
Pharmacy Learning Network
News
FDA Issues Class II Recalls for Multiple Injectable Products Due to Sterility Concerns
04/17/2025
Hannah Musick
The US Food and Drug Administration (FDA) has issued Class II recalls for multiple injectable products, including Haloperidol Decanoate and Methocarbamol, due to potential sterility issues linked to bacterial contamination during...
The US Food and Drug Administration (FDA) has issued Class II recalls for multiple injectable products, including Haloperidol Decanoate and Methocarbamol, due to potential sterility issues linked to bacterial contamination during...
The US Food and Drug...
04/17/2025
Pharmacy Learning Network
News
FDA Class III Recall: Tolterodine Tartrate ER Capsules by Major Pharmaceuticals
04/10/2025
Danielle Sposato
A nationwide recall has been initiated for Tolterodine Tartrate Extended-Release Capsules, 2 mg, packaged in 30-count unit dose cartons (NDC 0904-6592-04), and distributed by Major Pharmaceuticals of Indianapolis, IN.
A nationwide recall has been initiated for Tolterodine Tartrate Extended-Release Capsules, 2 mg, packaged in 30-count unit dose cartons (NDC 0904-6592-04), and distributed by Major Pharmaceuticals of Indianapolis, IN.
A nationwide recall has been...
04/10/2025
Pharmacy Learning Network
News
Imprimis NJOF Voluntarily Recalls Ophthalmic Solution Due to Subpotency
04/10/2025
Danielle Sposato
Imprimis NJOF, LLC has issued a voluntary recall of its Tropicamide - Proparacaine - Phenylephrine - Ketorolac Sterile Ophthalmic Solution (1% / 0.5% / 2.5% / 0.5%) after stability testing revealed subpotent results.
Imprimis NJOF, LLC has issued a voluntary recall of its Tropicamide - Proparacaine - Phenylephrine - Ketorolac Sterile Ophthalmic Solution (1% / 0.5% / 2.5% / 0.5%) after stability testing revealed subpotent results.
Imprimis NJOF, LLC has issued a...
04/10/2025
Pharmacy Learning Network
News
Class II Recall Issued for Chlorpromazine Tablets Due to Nitrosamine Impurity
04/10/2025
Danielle Sposato
Glenmark Pharmaceuticals Inc., USA has initiated a voluntary Class II recall of its chlorproMAZINE Hydrochloride Tablets, USP 100 mg, due to current Good Manufacturing Practice (CGMP) deviations
Glenmark Pharmaceuticals Inc., USA has initiated a voluntary Class II recall of its chlorproMAZINE Hydrochloride Tablets, USP 100 mg, due to current Good Manufacturing Practice (CGMP) deviations
Glenmark Pharmaceuticals Inc.,...
04/10/2025
Pharmacy Learning Network
News
FDA Issues Class II Recall for QuVa Pharma Compounded Epidural Drug Products Due to Sterility Concerns
04/03/2025
Juliet Gallagher
QuVa Pharma, Inc. has voluntarily initiated a nationwide Class II recall of multiple compounded epidural drug formulations containing fentanyl citrate combined with bupivacaine or ropivacaine.
QuVa Pharma, Inc. has voluntarily initiated a nationwide Class II recall of multiple compounded epidural drug formulations containing fentanyl citrate combined with bupivacaine or ropivacaine.
QuVa Pharma, Inc. has...
04/03/2025
Pharmacy Learning Network

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2025 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use